Russia’s second candidate vaccine against the coronavirus is less than a month away from state approval after completing small-scale human trials, the vaccine’s developers have said this week.
The Siberia-based Vektor State Virology and Biotechnology Center concluded Phase 2 trials on 100 volunteers last week, with results due to be published Wednesday. Volunteers were said to be “feeling good” after taking the peptide-based jab called EpiVacCorona.
The Russian government plans to approve EpiVacCorona sometime around Oct. 15, Interfax reported, after which Vektor will begin large-scale trials on 5,000 volunteers.
Vektor head Rinat Maksyutov estimates that EpiVacCorona will require booster doses every three years.
“After the vaccination cycle, the next revaccination will be required no more than once every three years,” Maksyutov said in a preview of a state television documentary about Covid-19 vaccines published Thursday.
Russia’s first coronavirus vaccine, Sputnik V, was the first in the world to receive government approval last month, and large-scale post-registration trials are currently underway on 40,000 volunteers. Its developer has said that booster shots for Sputnik V would be required every two years.
Russia’s number of new Covid-19 cases has seen a gradual rise from below 5,000 per day in mid-to-late August to more than 6,000 in the past five days.
More than 1.12 million cases have been officially confirmed in Russia, the fourth-highest number of infections in the world.
The Vektor laboratory complex, based in the Siberian city of Novosibirsk, conducted secret biological weapons research in the Soviet era and stockpiles viruses ranging from Ebola to smallpox.
A Message from The Moscow Times:
Dear readers,
We are facing unprecedented challenges. Russia's Prosecutor General's Office has designated The Moscow Times as an "undesirable" organization, criminalizing our work and putting our staff at risk of prosecution. This follows our earlier unjust labeling as a "foreign agent."
These actions are direct attempts to silence independent journalism in Russia. The authorities claim our work "discredits the decisions of the Russian leadership." We see things differently: we strive to provide accurate, unbiased reporting on Russia.
We, the journalists of The Moscow Times, refuse to be silenced. But to continue our work, we need your help.
Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just $2. It's quick to set up, and every contribution makes a significant impact.
By supporting The Moscow Times, you're defending open, independent journalism in the face of repression. Thank you for standing with us.
Remind me later.
